What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Genzyme
100%DGNews: Addition of Alemtuzumab to Fludarabine Improves Progression-Free Survival in Patients With Chronic Lymphocytic Leukaemia: Presented at EHA
97%DGNews: CRADA Signed to Develop Treatment for Severe Skin Cancer
96%DGNews: FDA Grants Orphan Drug Designation to Recombinant Human Antithrombin III for Anticoagulation
95%DGNews: FDA Approves Fabrazyme (Agalsidase Beta) For Treatment Of Fabry Disease
95%DGNews: FDA Panel Backs Efficacy, Safety Of Aldurazyme For Mucopolysaccharidosis I
95%DGNews: Genzyme Receives Approval for Thyrogen in Canada
95%DGNews: France Allows Fabrazyme (Agalsidase Beta) Treatment For Fabry Disease
95%DGNews: N-geneous Automated HDL Cholesterol Test Launched in the U.S.
95%DGNews: ATIII Safe in Clinical Trial, IND Filed for Phase II Trial
95%DGNews: Orphan Drug Designations for NeuroCell-PD and NeuroCell-HD
94%DGNews: Long-term Success of Cerezyme Therapy Described in New Publication
94%DGNews: Genzyme Biosurgery Gains European Approval for Synvisc in the Hip
94%DGNews: Europe Approves Fabrazyme (Agalsidase Beta) for Fabry Disease
94%DGNews: ATIII Phase II Clinical Trial Begins in the United States
93%DGNews: Europe Approves Renagel Capsules For Hyperphosphatemia In Hemodialysis
92%DGNews: Positive Synvisc Data Presented at European Conference
92%DGNews: European Commission Approves First Treatment for Pompe Disease
92%DGNews: FDA Approves Renagel Tablets (Sevelamer Hydrochloride) For Hemodialysis Patients
91%DGNews: Genzyme Receives European Approval for Hylan G-F 20 in Ankle and Shoulder Osteoarthritis Indications
91%DGNews: FDA Approves Genzyme's Myozyme (Alglucosidase Alfa) for All Patients with Pompe Disease
91%DGNews: Myozyme Receives Positive Opinion from European Regulatory Committee
91%DGNews: Europe Approves Thyrogen (Thyrotropin Alfa) for Use in Thyroid Cancer Ablation
91%DGNews: Health Canada Approves Enzyme Replacement Therapy, (Pr)Fabrazyme, for Fabry Disease
90%DGNews: Breakthrough Technology Reduces Post-Surgical Complications
89%DGNews: Clolar (Clofarabine) Wins FDA Approval for Most Common Pediatric Leukemia
88%DGNews: Tolevamer Fails in Phase 3 Diarrhea Trial: Presented at ICAAC
88%DGNews: First Therapy Ever Approved in Canada for Ultra-Rare Form of Muscular Dystrophy
88%DGNews: Fabrazyme (Agalsidase Beta) Shows Promise for Fabry Disease
87%DGNews: Combination Therapy Stops Loss of Kidney Function in Rare Genetic Disease
87%DGNews: Genzyme Announces Publication of Study Showing Impact of Imiglucerase for Injection on Bone Health for Patients With Type 1 Gaucher Disease
87%DGNews: Study of Tolevamer for C. difficile-Associated Diarrhea Published in Clinical Infectious Diseases
87%DGNews: New Canadian Guidelines Reduce Cardiac Disease in Patients on Dialysis
87%DGNews: ASH MEETING: Vaccine Produces Tumour-Specific Immune Responses
86%DGNews: BioMarin Announces Marketing Approval for Aldurazyme in Japan
86%DGNews: MPS-I Patients Taking Alpha-L-Iduronidase Show Marked Improvement, Study Shows
86%DGNews: FDA Approves Thyrogen For Thyroid Cancer
86%DGNews: FDA Approves Renagel Capsules For Patients With End Stage Renal Disease
86%DGNews: AAOS: Patients Treated With Carticel Show Sustained Improvement At Four Years
85%DGNews: A Second Cycle of Injectable Hyaluronic Acid for Knee Osteoarthritis Pain Is Safe, Effective: Presented at EULAR
85%DGNews: Infection-Related Deaths Reported With Alemtuzumab, Warns Health Canada
85%DGNews: Renagel in New Dialysis Study Published in Kidney International
85%DGNews: DG DISPATCH - AAOS: Hylan G-F 20 Injections Clinically And Cost-Effective For Knee Osteoarthritis
84%DGNews: Phase 2 Clinical Trial for Gene Transfer Drug Study for Leg Pain
84%DGNews: DG DISPATCH - AAOS: Visco-Supplementation May Be Used To Treat Hip Arthritis
84%DGNews: Gene Therapy Can Help Improve Cystic Fibrosis
83%DGNews: Latest Data Confirm Benefits of Clofarabine in Children With Relapsed/Refractory Acute Leukaemia
83%DGNews: Genzyme Granted Label Change for Thyrogen
82%DGNews: Metronidazole as Effective as Vancomycin for [Clostridium Difficile Diarrhoea, and Tolevamer Reduces Recurrence: Presented at ECCMID</a></td>
82%</td><td><a href="http://www.pslgroup.com/dg/1FEC6E.htm"><b>DGNews: </b>ENDO: Thyrogen (Thyrotropin Alfa) Important Tool in Detecting Thyroid Cancer Recurrence</a></td>
81%</td><td><a href="http://www.pslgroup.com/dg/235A92.htm"><b>DGNews: </b>Health Canada Approves Hylan GF-20 for Osteoarthritis of the Knee</a></td>

<center><hr width=100%></center>
<b>Enter keywords you wish to find information about:</b><BR>
<INPUT NAME="Key" VALUE="Genzyme" Size="50"><INPUT TYPE=submit VALUE="Search"><p> <b>Search for documents that contain:</b><br><INPUT TYPE=radio NAME="AndOr" VALUE="0" CHECKED>any of these words.<BR> <INPUT TYPE=radio NAME="AndOr" VALUE="1">this exact phrase.<BR> <INPUT TYPE=radio NAME="AndOr" VALUE="2">all of these words.</form>
<p>&nbsp;
<p>&nbsp;
<center><hr width=100%></center>
<center><a href="http://www.pslgroup.com/docguide.htm"><img src="http://www.pslgroup.com/gif/buthome.gif" border=0><a href="http://www.pslgroup.com/search.htm"><img src="http://www.pslgroup.com/gif/butsearch.gif" border=0><a href="http://www.pslgroup.com/sitemap.htm"><img src="http://www.pslgroup.com/gif/butindex.gif" border=0>
<a href="http://www.pslgroup.com/sponsor.htm"><img src="http://www.pslgroup.com/gif/butspons.gif" border=0><a href="mailto:webmaster@pslgroup.com"><img src="http://www.pslgroup.com/gif/butemail.gif" border=0></a><p><hr width=100%><p><font size=-1>This site is maintained by <a href="mailto:webmaster@pslgroup.com"> webmaster@pslgroup.com</a>
<br>Please contact us with any comments, problems or bugs.<br><p><b>All contents <a href="http://www.pslgroup.com/COPYRGTH.HTM">Copyright</a> (c) 1998 PSL Consulting Group Inc.<br>all rights reserved.</b><p></font><br><a href="http://www.blissco.com"><img src="http://www.pslgroup.com/gif/blissball2.gif" border=0 align=middle></a></center></TD>
</TR></TABLE>]